Balyasny Asset Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-62,549
Closed -$2.32M 2294
2024
Q3
$2.32M Buy
+62,549
New +$2.32M ﹤0.01% 1086
2023
Q2
Sell
-91,436
Closed -$4.43M 2208
2023
Q1
$4.43M Sell
91,436
-9,496
-9% -$460K 0.01% 839
2022
Q4
$3.85M Buy
+100,932
New +$3.85M 0.01% 840
2022
Q2
Sell
-109,402
Closed -$4.08M 2615
2022
Q1
$4.08M Buy
109,402
+25,980
+31% +$969K 0.01% 796
2021
Q4
$3.32M Sell
83,422
-24,870
-23% -$991K 0.01% 842
2021
Q3
$4.03M Sell
108,292
-136,540
-56% -$5.08M 0.02% 736
2021
Q2
$10.3M Buy
+244,832
New +$10.3M 0.05% 458
2020
Q4
Sell
-5,489
Closed -$257K 1415
2020
Q3
$257K Sell
5,489
-2,109
-28% -$98.7K ﹤0.01% 963
2020
Q2
$386K Buy
+7,598
New +$386K ﹤0.01% 796
2019
Q4
Sell
-93,122
Closed -$3.15M 1284
2019
Q3
$3.15M Buy
93,122
+3,084
+3% +$104K 0.02% 548
2019
Q2
$4.05M Sell
90,038
-68,713
-43% -$3.09M 0.03% 566
2019
Q1
$5.98M Buy
+158,751
New +$5.98M 0.04% 470
2018
Q4
Sell
-700,692
Closed -$32.9M 1510
2018
Q3
$32.9M Buy
700,692
+392,931
+128% +$18.5M 0.15% 169
2018
Q2
$10.4M Buy
307,761
+81,228
+36% +$2.74M 0.05% 409
2018
Q1
$6.13M Buy
+226,533
New +$6.13M 0.03% 551
2017
Q4
Sell
-15,100
Closed -$302K 1951
2017
Q3
$302K Buy
+15,100
New +$302K ﹤0.01% 1328
2016
Q4
Sell
-330,000
Closed -$4.62M 1258
2016
Q3
$4.62M Buy
+330,000
New +$4.62M 0.03% 511
2015
Q2
Sell
-83,218
Closed -$5.06M 1051
2015
Q1
$5.06M Sell
83,218
-103,677
-55% -$6.31M 0.04% 349
2014
Q4
$9.68M Buy
+186,895
New +$9.68M 0.09% 245
2014
Q3
Sell
-41,820
Closed -$1.09M 601
2014
Q2
$1.09M Buy
+41,820
New +$1.09M 0.01% 385